Previous studies have suggested that heterozygous carriers of loss-of-function ABCG5 variants exhibit elevated levels of sitosterol and LDL-C, which may increase their risk of coronary artery disease [11,33]. This evidence concerns the gene ABCG5 and coronary artery disorder.